Integration of Molecular Docking and In Vitro Studies: A Powerful Approach for Drug Discovery in Breast Cancer
Molecular docking in the pharmaceutical industry is a powerful in silico approach for discovering novel therapies for unmet medical needs predicting drug–target interactions. It not only provides binding affinity between drugs and targets at the atomic level, but also elucidates the fundamental phar...
Main Authors: | Claudia Cava, Isabella Castiglioni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/19/6981 |
Similar Items
-
Applications of molecular docking in natural products-based drug discovery
by: Isaac Asiamah, et al.
Published: (2023-07-01) -
Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer
by: Md Shahin Alam, et al.
Published: (2022-09-01) -
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
by: Mahmoud Ganji, et al.
Published: (2023-02-01) -
Acylpolyamine Mygalin as a TLR4 Antagonist Based on Molecular Docking and In Vitro Analyses
by: Abraham Espinoza-Culupú, et al.
Published: (2020-12-01) -
Unlocking the potential of approved drugs for the allosteric inhibition of tropomyosin-receptor kinase A using molecular docking and molecular dynamics studies
by: Rua M. Mukhtar, et al.
Published: (2023-06-01)